Cargando…

Sex-Related Differences among Adults with Hypertrophic Obstructive Cardiomyopathy Undergoing Transcoronary Ablation of Septal Hypertrophy

(1) Background: The transcoronary ablation of septal hypertrophy (TASH) is an established therapy for hypertrophic obstructive cardiomyopathy (HOCM). Previous studies on this topic are characterised by a consistent male predominance and show a worse prognosis in females. (2) Methods: This study is a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alyaydin, Emyal, Vogel, Julia Kirsten, Luedike, Peter, Rassaf, Tienush, Jánosi, Rolf Alexander, Papathanasiou, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145340/ https://www.ncbi.nlm.nih.gov/pubmed/37109359 http://dx.doi.org/10.3390/jcm12083024

Ejemplares similares

Visualization of transcoronary ablation of septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: a comparison between cardiac MRI, invasive measurements and echocardiography
por: Sohns, Christian, et al.
Publicado: (2010)

Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
por: El Masry, Hicham, et al.
Publicado: (2008)

Severe Gastrointestinal Bleeding in a Patient With Subvalvular Aortic Stenosis Treated With Thalidomide and Octreotide: Bridging to Transcoronary Ablation of Septal Hypertrophy
por: Hvid-Jensen, Helene S., et al.
Publicado: (2015)

A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy
por: Shelke, Abhijeet B., et al.
Publicado: (2016)

Alcohol septal ablation in hypertrophic cardiomyopathy
por: Mateo, Juan José Santos, et al.
Publicado: (2018)

From 100 to 0: Endocardial Radiofrequency Ablation of Septal Hypertrophy for Management of Hypertrophic Cardiomyopathy
por: Peigh, Graham, et al.
Publicado: (2020)

Septal Ablation in Obstructive Hypertrophic Cardiomyopathy (oHCM)
por: Almeida, Dirceu Rodrigues
Publicado: (2019)

Alcohol Septal Ablation or Mavacamten for Obstructive Hypertrophic Cardiomyopathy
por: Scholtz, Smita, et al.
Publicado: (2023)

Transcoronary Ethanol Ablation For Ventricular Tachycardia
por: Francis, Johnson, et al.
Publicado: (2011)

Twenty Years of Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy
por: Rigopoulos, Angelos G., et al.
Publicado: (2016)

Role of endocardial septal ablation in the treatment of hypertrophic obstructive cardiomyopathy
por: Aksu, Tolga, et al.
Publicado: (2016)

Septal Ablation Versus Surgical Myomectomy for Hypertrophic Obstructive Cardiomyopathy
por: Pelliccia, F., et al.
Publicado: (2021)

Alcohol Septal Ablation: An Option on the Rise in Hypertrophic Obstructive Cardiomyopathy
por: Arévalos, Victor, et al.
Publicado: (2021)

Extreme septal hypertrophy in an adolescent with congenital familial hypertrophic cardiomyopathy
por: Park, Byoung-Won, et al.
Publicado: (2015)

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Is the Extent of Septal Hypertrophy Important?
por: Park, Kyoung-min, et al.
Publicado: (2016)

Left ventricular anatomy in obstructive hypertrophic cardiomyopathy: beyond basal septal hypertrophy
por: Hermida, Uxio, et al.
Publicado: (2022)

Surgical septal myectomy outcome for obstructive hypertrophic cardiomyopathy after alcohol septal ablation
por: Yang, Qiulan, et al.
Publicado: (2021)

Alcohol septal ablation in hypertrophic cardiomyopathy: For which patients?
por: Achim, Alexandru, et al.
Publicado: (2023)

Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: From Experiment to Standard of Care
por: Faber, Lothar
Publicado: (2014)

Alcohol septal ablation for hypertrophic obstructive cardiomyopathy – 8 years follow up
por: Sathyamurthy, I., et al.
Publicado: (2014)

Age‐related survival after alcohol septal ablation in hypertrophic obstructive cardiomyopathy
por: Batzner, Angelika, et al.
Publicado: (2021)

Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective
por: Gragnano, Felice, et al.
Publicado: (2023)

Hemodynamic Predictors of Outcome Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
por: Alabdaljabar, Mohamad S., et al.
Publicado: (2023)

Alcohol Septal Ablation or Septal Myectomy? An Updated Systematic Review and Meta-Analysis of Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy
por: Zheng, Xifeng, et al.
Publicado: (2022)

Concomitant ablation for atrial fibrillation during septal myectomy in patients with hypertrophic obstructive cardiomyopathy
por: Bogachev-Prokophiev, A, et al.
Publicado: (2015)

Comparison of the Clinical Features of Apical Hypertrophic Cardiomyopathy Versus Asymmetric Septal Hypertrophy in Korea
por: Yang, Hyun Suk, et al.
Publicado: (2005)

Transcoronary mapping using a guidewire during transcoronary ethanol ablation for ventricular tachycardia with a deep intramural substrate: a case report
por: Chiba, Suguru, et al.
Publicado: (2023)

Diagnosing cardiac amyloidosis in every-day practice: A practical guide for the cardiologist
por: Papathanasiou, Maria, et al.
Publicado: (2020)

Predictors of outcome after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. Special interest for the septal coronary anatomy
por: Steggerda, R. C., et al.
Publicado: (2013)

Alcohol Septal Ablation versus Septal Myectomy Treatment of Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis
por: Bytyçi, Ibadete, et al.
Publicado: (2020)

Cerclage Septal Ablation for Hypertrophic Cardiomyopathy: Will a Backdoor Attack on the Septum Be Better?
por: Bach, Richard G.
Publicado: (2020)

Percutaneous septal ablation for left mid-ventricular obstructive hypertrophic cardiomyopathy: a case report
por: Tengiz, Istemihan, et al.
Publicado: (2006)

How Symptomatic Should a Hypertrophic Obstructive Cardiomyopathy Patient Be to Consider Alcohol Septal Ablation?
por: Jones, Brandon M., et al.
Publicado: (2017)

Outcome of patients ≥ 60 years of age after alcohol septal ablation for hypertrophic obstructive cardiomyopathy
por: Jahnlová, Denisa, et al.
Publicado: (2019)

Selective Interventricular Septal Radiofrequency Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy: Who Can Benefit?
por: Liu, Qiang, et al.
Publicado: (2021)

Transcoronary electrophysiological parameters in patients undergoing elective and acute coronary intervention
por: Javid, Rabeia, et al.
Publicado: (2023)

Robotic septal myectomy for hypertrophy cardiomyopathy
por: Cheng, Bor-Chih, et al.
Publicado: (2022)

Resternotomy does not adversely affect outcome after left ventricular assist device implantation
por: Papathanasiou, Maria, et al.
Publicado: (2017)

Predictive potential of macrophage migration inhibitory factor (MIF) in patients with heart failure with preserved ejection fraction (HFpEF)
por: Luedike, Peter, et al.
Publicado: (2018)

(18)F-florbetaben positron emission tomography detects cardiac involvement in systemic AA amyloidosis
por: Papathanasiou, Maria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f32ml2o1q75qs04kr5rpcdnls0